COMPANY

TechnoVax

HQ: Elmsford, NY source · technovax.com ↗ · Mid-Atlantic

Keywords: vaccine

Location: Elmsford, NY · source · Oct 15, 2026

Profile checked Oct 10, 2026

11NIH grants

NIH awards 11

Annual award amounts. Total $6.8M.

Aug 3, 2020 NIH award 1R43AI145499-01A1 FY2020: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI GALARZA, JOSE M.; recipient as written: TECHNOVAX, INC., ELMSFORD, NY. Production and Testing of VLP-based RSV Vaccin source ↗
Aug 1, 2019 NIH award 5R44AI106145-04 FY2019: $734,219 awarded for that fiscal year; activity R44 (SBIR); PI GALARZA, JOSE M.; recipient as written: TECHNOVAX, INC., ELMSFORD, NY. Universal VLP-Based Flu Vaccine:Broadly protecti source ↗
Aug 28, 2018 NIH award 2R44AI106145-03 FY2018: $746,924 awarded for that fiscal year; activity R44 (SBIR); PI GALARZA, JOSE M.; recipient as written: TECHNOVAX, INC., ELMSFORD, NY. Universal VLP-Based Flu Vaccine:Broadly protecti source ↗
May 16, 2014 NIH award 1R43AI108099-01A1 FY2014: $509,623 awarded for that fiscal year; activity R43 (SBIR); PI GALARZA, JOSE M.; recipient as written: TECHNOVAX, INC., ELMSFORD, NY. Development, Production and Testing of VLP bas source ↗
May 13, 2014 NIH award 5R43AI106145-02 FY2014: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI GALARZA, JOSE M.; recipient as written: TECHNOVAX, INC., ELMSFORD, NY. Broadly protective (universal) virus-like partic source ↗
May 29, 2013 NIH award 1R43AI106145-01A1 FY2013: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI GALARZA, JOSE M.; recipient as written: TECHNOVAX, INC., ELMSFORD, NY. Broadly protective (universal) virus-like part source ↗
Aug 10, 2011 NIH award 5R44AI063830-05 FY2011: $1,153,679 awarded for that fiscal year; activity R44 (SBIR); PI GALARZA, JOSE M.; recipient as written: TECHNOVAX, INC., ELMSFORD, NY. Development of Influenza Virus-Like Particle ( source ↗
Aug 24, 2010 NIH award 5R44AI063830-04 FY2010: $971,080 awarded for that fiscal year; activity R44 (SBIR); PI GALARZA, JOSE M.; recipient as written: TECHNOVAX, INC., ELMSFORD, NY. Development of Influenza Virus-Like Particle (VL source ↗
Sep 1, 2009 NIH award 2R44AI063830-03A1 FY2009: $822,755 awarded for that fiscal year; activity R44 (SBIR); PI GALARZA, JOSE M.; recipient as written: TECHNOVAX, INC., ELMSFORD, NY. Development of Influenza Virus-Like Particle ( source ↗
Jun 26, 2006 NIH award 5R43AI063830-02 FY2006: $499,800 awarded for that fiscal year; activity R43 (SBIR); PI GALARZA, JOSE M; recipient as written: TECHNOVAX, INC., TARRYTOWN, NY. Influenza Virus-like Particles As Vaccines source ↗
Apr 14, 2005 NIH award 1R43AI063830-01 FY2005: $510,242 awarded for that fiscal year; activity R43 (SBIR); PI GALARZA, JOSE M; recipient as written: TECHNOVAX, INC., TARRYTOWN, NY. Influenza Virus-like Particles As Vaccines source ↗